1
|
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
|
Ann Rheum Dis
|
2010
|
2.71
|
2
|
Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
|
J Rheumatol
|
2009
|
2.03
|
3
|
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.
|
Arthritis Rheum
|
2011
|
1.56
|
4
|
Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders.
|
Ann N Y Acad Sci
|
2007
|
1.21
|
5
|
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.
|
Clin Rheumatol
|
2004
|
1.18
|
6
|
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies.
|
J Rheumatol
|
2010
|
1.17
|
7
|
Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
|
Arthritis Rheum
|
2012
|
1.06
|
8
|
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
|
J Rheumatol
|
2010
|
1.02
|
9
|
Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response.
|
J Rheumatol
|
2010
|
0.99
|
10
|
Thymic and bone marrow output in patients with common variable immunodeficiency.
|
J Clin Immunol
|
2011
|
0.99
|
11
|
Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients.
|
J Rheumatol
|
2010
|
0.95
|
12
|
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
|
Arthritis Rheum
|
2006
|
0.95
|
13
|
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
|
J Rheumatol
|
2010
|
0.89
|
14
|
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
|
Rheumatology (Oxford)
|
2010
|
0.86
|
15
|
Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.
|
J Rheumatol
|
2014
|
0.84
|
16
|
Single-center analysis of long-term outcome after hematopoietic cell transplantation in children with congenital severe T cell immunodeficiency.
|
Immunol Res
|
2009
|
0.83
|
17
|
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
|
Medicine (Baltimore)
|
2015
|
0.83
|
18
|
Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab.
|
Rheumatol Int
|
2015
|
0.82
|
19
|
Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma.
|
Clin Rheumatol
|
2004
|
0.80
|
20
|
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study.
|
Arthritis Rheum
|
2011
|
0.80
|
21
|
The number of circulating recent thymic emigrants is severely reduced 1 year after a single dose of alemtuzumab in renal transplant recipients.
|
Transpl Int
|
2010
|
0.79
|
22
|
Targeting CD4+CD28- T cells by blocking CD28 co-stimulation.
|
Trends Mol Med
|
2012
|
0.78
|
23
|
Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy.
|
AIDS
|
2003
|
0.76
|
24
|
Flow cytometry test to screen for HLA-B*58:01-associated allopurinol hypersensitivity.
|
Clin Rheumatol
|
2014
|
0.75
|
25
|
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.
|
Clin Rheumatol
|
2014
|
0.75
|
26
|
T-lymphocyte production, function, and death in children who recovered from opsoclonus-myoclonus syndrome.
|
Pediatr Hematol Oncol
|
2006
|
0.75
|
27
|
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysis.
|
Rheumatology (Oxford)
|
2013
|
0.75
|